Sabrina Malvagia

2.6k total citations
55 papers, 1.6k citations indexed

About

Sabrina Malvagia is a scholar working on Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Sabrina Malvagia has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Clinical Biochemistry, 22 papers in Pediatrics, Perinatology and Child Health and 14 papers in Molecular Biology. Recurrent topics in Sabrina Malvagia's work include Metabolism and Genetic Disorders (21 papers), Neonatal Health and Biochemistry (15 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Sabrina Malvagia is often cited by papers focused on Metabolism and Genetic Disorders (21 papers), Neonatal Health and Biochemistry (15 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Sabrina Malvagia collaborates with scholars based in Italy, United States and Netherlands. Sabrina Malvagia's co-authors include Giancarlo la Marca, Renzo Guerrini, Maria Alice Donati, Enrico Zammarchi, Luca Filippi, Elisabetta Pasquini, Daniela Ombrone, Marzia Innocenti, G Forni and Amelia Morrone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Clinical Chemistry.

In The Last Decade

Sabrina Malvagia

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabrina Malvagia Italy 26 562 545 489 271 255 55 1.6k
Bruno Casetta Italy 24 335 0.6× 818 1.5× 243 0.5× 74 0.3× 134 0.5× 41 1.8k
Mark J Magera United States 19 768 1.4× 874 1.6× 286 0.6× 99 0.4× 31 0.1× 25 1.8k
Jon A. Gangoiti United States 23 298 0.5× 758 1.4× 269 0.6× 51 0.2× 44 0.2× 42 1.6k
Ryoji Kojima Japan 19 151 0.3× 599 1.1× 261 0.5× 91 0.3× 118 0.5× 55 1.7k
E. Arrigoni‐Martelli Denmark 24 350 0.6× 586 1.1× 101 0.2× 114 0.4× 240 0.9× 90 1.6k
Minnie Jacob Saudi Arabia 15 286 0.5× 604 1.1× 110 0.2× 60 0.2× 50 0.2× 28 1.1k
Taro Tokui Japan 15 141 0.3× 524 1.0× 694 1.4× 29 0.1× 159 0.6× 25 2.7k
Hironori Nagasaka Japan 25 350 0.6× 508 0.9× 213 0.4× 62 0.2× 16 0.1× 88 1.6k
Ichiro Komiya Japan 30 64 0.1× 573 1.1× 101 0.2× 189 0.7× 135 0.5× 105 2.6k
Giuliana Leoncini Italy 23 178 0.3× 406 0.7× 75 0.2× 75 0.3× 263 1.0× 91 1.4k

Countries citing papers authored by Sabrina Malvagia

Since Specialization
Citations

This map shows the geographic impact of Sabrina Malvagia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Malvagia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Malvagia more than expected).

Fields of papers citing papers by Sabrina Malvagia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Malvagia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Malvagia. The network helps show where Sabrina Malvagia may publish in the future.

Co-authorship network of co-authors of Sabrina Malvagia

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Malvagia. A scholar is included among the top collaborators of Sabrina Malvagia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Malvagia. Sabrina Malvagia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malvagia, Sabrina, G Forni, Daniela Ombrone, & Giancarlo la Marca. (2020). Development of Strategies to Decrease False Positive Results in Newborn Screening. International Journal of Neonatal Screening. 6(4). 84–84. 34 indexed citations
2.
Forni, G, Sabrina Malvagia, Silvia Funghini, et al.. (2018). LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization. Clinica Chimica Acta. 488. 98–103. 19 indexed citations
3.
Forni, G, Sabrina Malvagia, Silvia Funghini, et al.. (2018). Data in support for the measurement of heparan sulfate and dermatan sulfate by LC–MS/MS analysis. Data in Brief. 21. 2398–2404. 1 indexed citations
4.
Ombrone, Daniela, Elisa Giocaliere, G Forni, Sabrina Malvagia, & Giancarlo la Marca. (2015). Expanded newborn screening by mass spectrometry: New tests, future perspectives. Mass Spectrometry Reviews. 35(1). 71–84. 97 indexed citations
5.
Sardi, Iacopo, Ornella Fantappiè, Giancarlo la Marca, et al.. (2014). Delivery of doxorubicin across the blood–brain barrier by ondansetron pretreatment: a study in vitro and in vivo. Cancer Letters. 353(2). 242–247. 25 indexed citations
6.
Bona, Maria Luisa Della, Sabrina Malvagia, Fabio Villanelli, et al.. (2013). A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots. Journal of Pharmaceutical and Biomedical Analysis. 78-79. 34–38. 21 indexed citations
7.
Marca, Giancarlo la, Elisa Giocaliere, Sabrina Malvagia, et al.. (2013). The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 88. 201–206. 27 indexed citations
8.
Marca, Giancarlo la, Anna Rosati, Sabrina Malvagia, et al.. (2013). A Pharmacokinetic Study and Correlation with Clinical Response of Rufinamide in Infants with Epileptic Encephalopathies. Pharmacology. 91(5-6). 275–280. 7 indexed citations
9.
Marca, Giancarlo la, Elisa Giocaliere, Fabio Villanelli, et al.. (2011). Development of an UPLC–MS/MS method for the determination of antibiotic ertapenem on dried blood spots. Journal of Pharmaceutical and Biomedical Analysis. 61. 108–113. 46 indexed citations
10.
Marca, Giancarlo la, Sabrina Malvagia, Elisabetta Pasquini, et al.. (2011). Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential. JIMD Reports. 1. 107–109. 12 indexed citations
11.
Filippi, Luca, Giancarlo la Marca, Patrizio Fiorini, et al.. (2009). Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia. 50(11). 2355–2361. 64 indexed citations
12.
Filippi, Luca, Elena Gozzini, Patrizio Fiorini, et al.. (2009). <i>N</i>-Carbamylglutamate in Emergency Management of Hyperammonemia in Neonatal Acute Onset Propionic and Methylmalonic Aciduria. Neonatology. 97(3). 286–290. 43 indexed citations
13.
Houtkooper, Riekelt H., Marjolein Turkenburg, Bwee Tien Poll‐The, et al.. (2009). The enigmatic role of tafazzin in cardiolipin metabolism. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1788(10). 2003–2014. 124 indexed citations
14.
Marca, Giancarlo la, Sabrina Malvagia, Luca Filippi, et al.. (2009). A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC‐tandem mass spectrometry. Epilepsia. 50(12). 2658–2662. 47 indexed citations
15.
Marca, Giancarlo la, Bruno Casetta, Sabrina Malvagia, et al.. (2006). Implementing tandem mass spectrometry as a routine tool for characterizing the complete purine and pyrimidine metabolic profile in urine samples. Journal of Mass Spectrometry. 41(11). 1442–1452. 28 indexed citations
16.
Malvagia, Sabrina, Amelia Morrone, Elisabetta Pasquini, et al.. (2005). First prenatal molecular diagnosis in a family with holocarboxylase synthetase deficiency. Prenatal Diagnosis. 25(12). 1117–1119. 3 indexed citations
17.
Cavicchi, Catia, Silvia Funghini, Giancarlo la Marca, et al.. (2005). Genetic and biochemical approach to early prenatal diagnosis in a family with mut methylmalonic aciduria. Clinical Genetics. 69(1). 72–76. 8 indexed citations
18.
Malvagia, Sabrina, Elisabetta Pasquini, Maria Alice Donati, et al.. (2003). The De Novo Q167K Mutation in the POU1F1 Gene Leads to Combined Pituitary Hormone Deficiency in an Italian Patient. Pediatric Research. 54(5). 635–640. 20 indexed citations
19.
Marca, Giancarlo la, Sabrina Malvagia, Maria Alice Donati, et al.. (2003). Rapid diagnosis of medium chain Acyl Co‐A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 17(23). 2688–2692. 10 indexed citations
20.
Morrone, Amelia, Sabrina Malvagia, Maria Alice Donati, et al.. (2002). Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency. American Journal of Medical Genetics. 111(1). 10–18. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Casetta Breakdown of academic impact, for papers by Mark J Magera Breakdown of academic impact, for papers by Jon A. Gangoiti Breakdown of academic impact, for papers by Ryoji Kojima Breakdown of academic impact, for papers by E. Arrigoni‐Martelli Breakdown of academic impact, for papers by Minnie Jacob Breakdown of academic impact, for papers by Taro Tokui Breakdown of academic impact, for papers by Hironori Nagasaka Breakdown of academic impact, for papers by Ichiro Komiya Breakdown of academic impact, for papers by Giuliana Leoncini
Rankless by CCL
2026